Arash Mostaghimi, MD, MPH, FAAD
SESSIONS
S065 Great Care for Common Conditions: Combining Evidence and Cost Effectiveness
Mar 10, 2025
•
1:00 PM - 4:00 PM
•
Valencia Ballroom D
U100 Medical Dermatology Potpourri: Challenges Faced and Lessons Learned
Mar 10, 2025
•
4:30 PM - 5:30 PM
•
W414C
DISCLOSURES
AbbVie – Consultant(Fees); ACOM – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees), Speaker(Fees); Digital Diagnostics – Consultant(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Equillium, Inc. – Consultant(Fees); Figure 1 Beauty, Inc. – Advisory Board(Stock); hims – Advisory Board(Stock); Incyte Corporation – Investigator(Grants/Research Funding); Olaplex – Advisory Board(Fees); Pelage Pharmaceuticals – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Consultant(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees);